-+ 0.00%
-+ 0.00%
-+ 0.00%

Medicus Pharma Reports Phase 2 SkinJect D-MNA Data Showing 73% Clinical Clearance in Basal Cell Carcinoma

Reuters·03/05/2026 12:31:17

Please log in to view news